Merit Medical Systems vs. Cooper Companies: A Comprehensive Comparison

Merit Medical Systems (NASDAQ:MMSI) and Cooper Companies (NASDAQ:COO) are two prominent players in the medical sector, but their business models and market positions differ significantly. A recent analysis evaluates their profitability, analyst recommendations, institutional ownership, risk profiles, earnings, dividends, and overall valuation, providing insights for potential investors.

Analyst Ratings and Market Potential

According to data from MarketBeat.com, the consensus price target for Merit Medical Systems stands at $107.50, indicating a potential upside of 27.66%. Meanwhile, Cooper Companies has a consensus price target of $84.75, reflecting a potential upside of 20.28%. With a stronger consensus rating and higher upside, analysts suggest that Merit Medical Systems is currently viewed more favorably than Cooper Companies.

Financial Performance and Valuation

A comparative analysis reveals that Cooper Companies boasts higher revenue and earnings per share (EPS) than Merit Medical Systems. Notably, Cooper Companies is trading at a lower price-to-earnings ratio, making it appear more affordable relative to its earnings potential. This discrepancy in financial metrics may appeal to different types of investors, depending on their strategies and risk appetites.

In terms of profitability, Merit Medical Systems and Cooper Companies exhibit differences in net margins, return on equity, and return on assets. These metrics are critical for assessing operational efficiency and the ability to generate profit from investments.

Ownership Structure and Institutional Confidence

Institutional ownership also plays a vital role in evaluating these companies. An impressive 99.7% of Merit Medical Systems shares are held by institutional investors, suggesting strong confidence in its future growth. In contrast, only 24.4% of Cooper Companies shares are owned by such investors. Furthermore, 3.2% of Merit Medical’s shares are held by company insiders, compared to 2.0% for Cooper Companies, indicating a greater alignment of interests between the company’s leadership and its shareholders.

Strong institutional ownership often indicates that large investors, such as mutual funds and hedge funds, foresee long-term growth potential. This factor may influence individual investors’ decisions when evaluating the two companies.

Company Profiles: Merit Medical Systems and Cooper Companies

Merit Medical Systems, founded in 1987 and headquartered in South Jordan, Utah, specializes in manufacturing single-use medical products for interventional, diagnostic, and therapeutic procedures. The company operates in two segments: Cardiovascular and Endoscopy. Its diverse product offerings include micropuncture kits, angiographic needles, and various oncology and cardiac intervention products, sold directly to healthcare providers or through distributors.

Conversely, Cooper Companies, established in 1958 and based in San Ramon, California, focuses on developing and manufacturing products primarily for contact lens wearers through its two segments: CooperVision and CooperSurgical. While CooperVision provides a range of contact lenses, CooperSurgical specializes in family and women’s health care products, including fertility solutions and medical devices.

Both companies exhibit unique strengths and market positions, making them appealing to different types of investors. Ultimately, the choice between Merit Medical Systems and Cooper Companies may depend on individual investment goals and risk tolerance.

For those interested in receiving updates on these companies, a concise daily summary of the latest news and analyst ratings is available through MarketBeat.com’s free email newsletter.